Citadel Advisors - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 51 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$197,000
-19.9%
160,768
+35.5%
0.00%
Q1 2022$246,000
-17.4%
118,685
-41.8%
0.00%
Q4 2021$298,000
-53.1%
203,797
-15.0%
0.00%
Q3 2021$635,000
-49.8%
239,699
-25.0%
0.00%
Q2 2021$1,266,000
+3.4%
319,788
+24.6%
0.00%
Q1 2021$1,224,000
+51.1%
256,631
+123.9%
0.00%
Q4 2020$810,000
-66.2%
114,600
-49.7%
0.00%
Q3 2020$2,399,000
+30.6%
227,831
+9.6%
0.00%
-100.0%
Q2 2020$1,837,000
+709.3%
207,800
+234.9%
0.00%
Q1 2020$227,000
+467.5%
62,044
+485.3%
0.00%
Q3 2019$40,00010,6000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 837,898$1,734,0000.84%
Green Alpha Advisors, LLC 78,159$162,0000.11%
Values First Advisors, Inc. 49,485$102,0000.06%
SHELTON CAPITAL MANAGEMENT 128,532$266,0000.01%
Archford Capital Strategies, LLC 13,091$29,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$347,0000.01%
Halpern Financial, Inc. 5,800$12,0060.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$145,0000.00%
TOWNSQUARE CAPITAL LLC 23,938$50,0000.00%
Newbridge Financial Services Group, Inc. 1,200$2,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders